Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Blood Biomarkers to Predict Gastric Cancer Risk

NCT04329299 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT04329299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04329299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Blood Biomarkers to Predict Gastric Cancer Risk
Lead sponsor
National University Hospital, Singapore
Phase
Observational
Overall status
Completed
Start date
December 3, 2012
Completion date
May 29, 2016
Enrollment
6,862 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

stomach neoplasm